On the identification of biomarkers for non-small cell lung cancer in serum and pleural effusion

Journal of Proteomics

Volumn 73, Issue 8, 2010, Pages 1511-1522

  Rodriguez Pineiro A M ^a   Blanco Prieto, S ^a   Sanchez Otero N ^a   Rodriguez Berrocal F J ^a   Paez de la Cadena M ^a  

^a UNIVERSITY OF VIGO   (Spain)

Author keywords

DIGE; Lung cancer; Pigment epithelium derived factor; Pleural effusion; Serum

Indexed keywords

ACTIN CYTOPLASMIC 1; ALBUMIN; ALPHA1 B GLYCOPROTEIN; APOLIPOPROTEIN A1; BETA 2 MICROGLOBULIN; BLOOD CLOTTING FACTOR; CALGRANULIN A; CALGRANULIN B; COMPLEMENT COMPONENT C3; CYTOPLASM PROTEIN; FIBRINOGEN BETA CHAIN; FIBRINOGEN GAMMA CHAIN; GELSOLIN; GLYCOPROTEIN; HEMOPEXIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN GAMMA 1 CHAIN C REGION; METALLOPROTEINASE INHIBITOR; METALLOPROTEINASE INHIBITOR 2; PIGMENT EPITHELIUM DERIVED FACTOR; PLASMA PROTEIN; SERUM AMYLOID A 4 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AFFINITY CHROMATOGRAPHY; AGED; AMINO ACID SEQUENCE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BINDING AFFINITY; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNODETECTION; LUNG NON SMALL CELL CANCER; MALE; PLEURA EFFUSION; PNEUMONIA; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUBERCULOSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EYE PROTEINS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PNEUMONIA; PROTEIN ISOFORMS; PROTEOMICS; SERPINS; TUBERCULOSIS, PULMONARY; TUMOR MARKERS, BIOLOGICAL;

EID: 77953122321     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2010.03.005     Document Type: Article

References (38)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., and Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 (2007) 581-592
2. Wallace W.A.H. The challenge of classifying poorly differentiated tumours in the lung. Histopathology 54 (2009) 28-42
3. Sobin L.H., and Wittekind C.H. TNM classification of malignant tumours. 6th edition (2002), Wiley, New York 99-103
4. Cho W.C. Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer. Biomed Pharmacother 61 (2007) 515-519
5. Tarro G., Perna A., and Esposito C. Early diagnosis of lung cancer by detection of tumor liberated protein. J Cell Physiol 203 (2005) 1-5
6. Sung H.J., and Cho J.Y. Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep 41 (2008) 615-625
7. Heo S.H., Lee S.J., Ryoo H.M., Park J.Y., and Cho J.Y. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics 7 (2007) 4292-4302
8. Okano T.T., Kondo T., Kakisaka T., Fujii K., Yamada M., Kato H., et al. Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis. Proteomics 6 (2006) 3938-3948
9. Pérez Rodríguez E., and Villena Garrido M.V. Enfermedades de la pleura (2003), Monografías Neumomadrid, Madrid
10. Crawford S.E., Stellmach V., Ranalli M., Huang X., Huang L., Volpert O., et al. Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity. J Cell Sci 114 (2001) 4421-4428
11. Gornall A.G., Bardawill C.J., and David M.M. Determination of serum proteins by means of the biuret reaction. J Biol Chem 177 (1949) 751-766
12. Bradford M.M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Chem 72 (1976) 248-254
13. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
14. Ramagli L.S., and Rodriguez L.V. Quantization of microgram amounts of protein in two-dimensional polyacrylamide gel electrophoresis sample buffer. Electrophoresis 6 (1985) 559-563
15. Shevchenko A, Wilm M, Worm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996;68:850-8.
16. Rodríguez-Piñeiro A.M., Rodríguez-Berrocal F.J., and Páez de la Cadena M. Improvements in the search for potential biomarkers by proteomics: application of principal component and discriminant analyses for two-dimensional maps evaluation. J Chromatogr B Analyt Technol Biomed Life Sci 849 (2007) 251-260
17. Cho S.Y., Lee E.Y., Lee J.S., Kim H.Y., Park J.M., Kwon M.S., et al. Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map. Proteomics 5 (2005) 3386-3396
18. Jantz M.A., and Antony V.B. Pathophysiology of the pleura. Respiration 75 (2008) 121-133
19. Faca V., Pitteri S.J., Newcomb L., Glukhova V., Phanstiel D., Krasnoselsky A., et al. Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. J Proteome Res 6 (2007) 3558-3565
20. Coimbra Wagner I., Barros Guimaraes M.J., Neves da Silva L.K., Montenegro de Melo F., and Cartaxo Muniz M.T. Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA 21-1 and CIA 15-3 in patients with pleural effusion. J Brasil Pneumol 33 (2007) 185-191
21. Unlü M., Morgan M.E., and Minden J.S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18 (1997) 2071-2077
22. Dosaka-Akita H., Hommura F., Fujita H., Kinoshita I., Nishi M., Morikawa T., et al. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Cancer Res 58 (1998) 322-327
23. Shieh D.B., Godleski J., Herndon II J.E., Azuma T., Mercer H., Sugarbaker D.J., et al. Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma: the role of gelsolin expression. Cancer 85 (1999) 47-57
24. Garbacki N., Di Valentin E., Piette J., Cataldo D., Crahay C., and Colige A. trix metalloproteinase 12 silencing: a therapeutic approach to treat pathological lung tissue remodeling?. Pulm Pharmacol Ther 22 (2009) 267-278
25. Salama I., Malone P.S., Mihaimeed F., and Jones J.L. A review of the S100 proteins in cancer. Eur J Surg Oncol 34 (2008) 357-364
26. Foell D., Wittkowski H., Vogl T., and Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 81 (2007) 28-37
27. Steele F.R., Chader G.J., Johnson L.V., and Tombran-Tink J. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA 90 (1993) 1526-1530
28. Petersen S.V., Valnickova Z., and Enghild J.J. Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization. Biochem J 374 (2003) 199-206
29. Redegeld F.A., Caldwell C.C., and Sitkovsky M.V. Ecto-protein kinases: ecto-domain phosphorylation as a novel target for pharmacological manipulation?. Trends Pharmacol Sci 20 (1999) 453-459
30. Maik-Rachline G., Shaltiel S., and Seger R. Extracellular phosphorylation converts pigment epithelium-derived factor from a neurotrophic to an antiangiogenic factor. Blood 105 (2005) 670-678
31. Maik-Rachline G., and Seger R. Variable phosphorylation states of pigment-epithelium-derived factor differentially regulate its function. Blood 107 (2006) 2745-2752
32. Zhang L., Chen J., Ke Y., Mansel R.E., and Jiang W.G. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome. Int J Mol Med 17 (2006) 937-944
33. Uehara H., Miyamoto M., Kato K., Ebihara Y., Kaneko H., Hashimoto H., et al. Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Cancer Res 64 (2004) 3533-3537
34. Fernandez-Garcia N.I., Volpert O.V., and Jimenez B. Pigment epithelium-derived factor as a multifunctional antitumor factor. J Mol Med 85 (2007) 15-22
35. Chen J., Ye L., Zhang L., and Jiang W.G. The molecular impact of pigment epithelium-derived factor, PEDF, on lung cancer cells and the clinical significance. Int J Oncol 35 (2009) 159-166
36. Ogata N., Matsuoka M., Matsuyama K., Shima C., Tajika A., Nishiyama T., et al. Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy. J Clin Endocrinol Metab 92 (2007) 1176-1179
37. Liu H., Ren J.G., Cooper W.L., Hawkins C.E., Cowan M.R., and Tong P.Y. Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc Natl Acad Sci USA 101 (2004) 6605-6610
38. Hsieh W.Y., Chen M.W., Ho H.T., You T.M., and Lu Y.T. Identification of differentially expressed proteins in human malignant pleural effusions. Eur Respir J 28 (2006) 1178-1185